Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Prevention of cytotoxic T lymphocyte responses to factor IX-expressing hepatocytes by gene transfer-induced regulatory T cells

Dobrzynski, Eric, Fitzgerald, Julie C., Cao, Ou, Mingozzi, Federico, Wang, Lixin, Herzog, Roland W. · 2006 · Proceedings of the National Academy of Sciences

Abstract

Treatment of genetic disease such as the bleeding disorder hemophilia B [deficiency in blood coagulation factor IX (F.IX)] by gene replacement therapy is hampered by the risk of immune responses to the therapeutic gene product and to the gene transfer vector. Immune competent mice of two different strains were tolerized to human F.IX by hepatic gene transfer mediated by adenoassociated viral vector. These animals were subsequently challenged by systemic administration of an E1/E3-deleted adenoviral vector, which is known to induce a cytotoxic T lymphocyte response to the transgene product. Immune tolerance prevented cytotoxic T lymphocyte activation to F.IX and CD8 + cellular infiltrates in the liver. Moreover, a sustained and substantial increase in hepatic F.IX expression from the adenoviral vector was achieved despite in vitro T cell responses to adenoviral antigens. Cytolytic responses to therapeutic and to viral vector-derived antigens had been prevented in vivo by activation of regulatory CD4 + T cells, which mediated suppression of inflammatory lymphocyte responses to the liver. This result suggests that augmentation of regulatory T cell activation should provide new means to avoid destructive immune responses in gene transfer.

Overview

Integrity signals

Registry

Crossref · 10.1073/pnas.0508685103

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 31 references

Research works printed but not linked: 2

  1. Y. Yang, K. U. Jooss, Q. Su, H. C. Ertl, J. M. Wilson Gene Ther 3, 137–144 (1996).
  2. C. S. Manno, G. F. Pierce, B. Glader, V. R. Arruda, M. V. Ragni, J. Rasko, M. Ozelo, K. Hoots, P. Blatt, B. Konkle, et al. Nat. Med, 2006).

Cited by

See all 108

Metadata

Authors
Dobrzynski, E., Fitzgerald, J. C., Cao, O., Mingozzi, F., Wang, L., & Herzog, R. W.
Affiliations
  • Children's Hospital of Philadelphia (US)
  • University of Florida (US)
Venue
Proceedings of the National Academy of Sciences
Published
2006-03-10
Volume
103
Issue
12
Pages
4592-4597
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W1993774764
Cited by
105
References
31
Citations by year
2025: 1 · 2024: 3 · 2023: 3 · 2022: 4 · 2021: 2 · 2020: 4 · 2019: 3 · 2018: 6 · 2017: 7 · 2016: 3 · 2015: 2 · 2014: 10 · 2013: 8 · 2012: 5
FWCI
5.88
Type
journal article
Language
en
Open access
closed
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Heart, Lung, and Blood Institute (P01HL078810)
  • National Institute of Allergy and Infectious Diseases (R01 AI/HL 51390-01)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Health Sciences › Medicine › Hematology › Hemophilia Treatment and Research
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
hemophilia B, factor IX, gene replacement therapy, immune tolerance, regulatory T cells, cytotoxic T lymphocytes, adeno-associated virus vectors, adenoviral vector, CD4+ T cells, CD8+ T cell infiltration
MeSH terms
Adenoviridae, Animals, Cytotoxicity, Immunologic, Factor IX, Genetic Vectors, Immune Tolerance, Immunosuppression Therapy, Male, Mice, Inbred Strains, T-Lymphocytes, Cytotoxic, Genetic Therapy, Gene Transfer Techniques, Adoptive Transfer, Hepatocytes, T-Lymphocytes, Regulatory, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prevention of cytotoxic T lymphocyte responses to factor IX-expressing hepatocytes by gene transfer-induced regulatory T cells. https://app.cochat.ai/papers/10.1073/pnas.0508685103
The paper
Dobrzynski, E., Fitzgerald, J. C., Cao, O., Mingozzi, F., Wang, L., & Herzog, R. W. (2006). Prevention of cytotoxic T lymphocyte responses to factor IX-expressing hepatocytes by gene transfer-induced regulatory T cells. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0508685103

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.